Viral Antigens Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Component (Influenza Viral Antigens, Coronavirus Antigens, Zika Virus Antigens, Ebola Virus Antigens, Dengue Virus Antigens, Herpes Simplex Virus (HSV) Antigens, Rotavirus Viral Antigens, Hepatitis A-E Virus Antigens, Measles Virus Antigens, Mumps/Parotitis Virus Antigens, and Others); Technique (ELISA, Immunoassay, Hemagglutination, Radioimmunoassay (RIA), Immunoperoxidase Staining, Immunofluorescence, and Others); and End User (Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, and Research Institutes); and Geography

Publication Month: Dec 2020 | Report Code: TIPRE00017334 | No. of Pages: 200 | Category: Biotechnology | Status: Published

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The Viral Antigens market was valued at US$101.41 million in 2019 and is projected to reach US$ 236.80 million by 2027; it is expected to grow at a CAGR of 11.0% during 2020–2027.

A virus can infect all types of life forms, from plants and animals to archaea and bacteria. A viral antigen is a poison or toxic substance administered by these virulent entities, which induces immune reaction in its host. For instance, a viral antigen is determined by IFA in neutrophils and platelets from bone marrow or blood or in serum, saliva, tears, or plasma by ELISA. Nucleic amplification tests can also be used to determine the stage of infection. The best outcomes are obtained when antigens are measured through blood tests or serum

A virus can infect all types of life forms, from plants and animals to archaea and bacteria. A virus antigen is a poison or toxic substance administered by a virus that induces an immune reaction in its host. A viral protein is an antigen identified by the viral genome that can be recognized through a particular immunological response. A viral antigen is determined by IFA in neutrophils and platelets from bone marrow or blood or in serum, saliva, tears, or plasma by ELISA. Nucleic amplification tests can also be used to determine the stage of infection. The best outcomes are obtained when antigens are measured through blood tests or serum.

Lucrative Regions in Viral Antigens Market

Lucrative Regions in Viral Antigens Market

Get more information on this report :


Market Insights

Increased Acceptance of Viral Antigens in Vaccine Development Fuels Market Growth
A viral antigen is a toxin or other substance released by a virus that is capable of inducing an immune response (to create an antibody) in the host organism. A viral protein is a viral genome-specified antigen that can be recognized by a specific immunological response. Vaccination aims to establish immunity in the host that, in the event of an infectious pathogen, will prevent illness. Therefore, in its simplest form, vaccine development for viral diseases involves the distribution of antigens that induce virus-specific neutralizing antibodies and avoid the induction of any off-target antibodies.

The development and use of vaccines has greatly reduced the number of illnesses and diseases over the years. The introduction of a variety of new types of vaccines has been made possible through the manipulation of DNA, RNA, proteins and sugars, increased knowledge of immune response, and a major leap in genetic engineering. Development of attenuated mutants, expression of possible antigens in live vectors, and purification and direct synthesis of antigens in new systems have significantly enhanced the vaccine technology.

Products Insights
In terms of component, the Coronavirus antigens segment held the largest share of the viral antigens market in 2019, and is expected to continue its dominance and register a higher the highest CAGR in the market during the forecast period.

Viral Antigens Market, by Component – 2019 and 2027

Viral Antigens Market, by Component – 2019 and 2027

Get more information on this report :


Application Insights

Based on end user, the global viral antigens market is segmented into hospitals, clinics, laboratories, diagnostic centers, blood banks, and research institutes. The diagnostic centers segment held the largest share of the market in 2019, and the market for laboratories is expected to register grow at the highest CAGR during the forecast period.

A laboratory is a place where clinical specimen tests are conducted to collect information on the patient's health to help diagnose, treat, and prevent disease. Over the last few decades, there has been a significant revolution in viral diagnostic laboratories' services and their role in patients' clinical management. Laboratories differ in size and sophistication, providing a wide range of research facilities. More extensive services may be seen in Aacute care hospitals and medical centers might provide extensive services, where and 70% of clinical decisions are based on laboratory tests. Doctoral offices and clinics, and specialist nursing and long-term care facilities can have laboratories that offer more basic testing services. Accurate diagnosis of the virus requires laboratory examination of clinical specimens for the presence of viral antigens, viruses, or specific antibodies. Over the last few decades, there has been a significant revolution in viral diagnostic laboratories' service and their role in patients' clinical management.

Strategic Insights

Players operating in the viral antigens market adopt collaboration and partnership strategies to meet demands of end users through the introduction of technologically advanced offerings, and these strategies  significantly support the growth of the market.

By Component

  • Influenza Viral Antigens
  • Coronavirus Antigens
  • Zika Virus Antigens
  • Ebola Virus Antigens
  • Dengue Virus Antigens
  • Herpes Simplex Virus (HSV) Viral Antigens
  • Rotavirus Viral Antigens
  • Hepatitis A-E Virus Antigens
  • Measles Virus Antigens
  • Mumps/Parotitis Virus Antigens
  • Others

By Technique

  • ELISA
  • Immunoassay
  • Hemagglutination
  • Radioimmunoassay (RIA)
  • Immunoperoxidase Staining
  • Immunofluorescence
  • Others

By End User

  • Hospitals
  • Clinics
  • Laboratories
  • Diagnostic Centers
  • Blood Banks
  • Research Institutes

By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Russia
  • Asia Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
  • South and Central America
    • Brazil
    • Argentina

Company Profiles

  • Microbix Biosystems
  • BIO-RAD LABORATORIES INC.
  • Creative Diagnostics
  • Aalto Bio Reagents Ltd.
  • Advanced Biotechnologies Inc.
  • Prospec-Tany Technogene Ltd.
  • ACROBiosystems.
  • MERIDIAN BIOSCIENCE, INC.
  • Rekom Biotech S.L
  • LGC Limited

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Global Viral Antigens Market – By Component

1.3.2        Global Viral Antigens Market – By Technique

1.3.3        Global Viral Antigens Market – By End User

1.3.4        Global Viral Antigens Market – By Geography

2.             Viral Antigens Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Viral Antigens Market – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America– PEST Analysis

4.2.2        Europe– PEST Analysis

4.2.3        Asia Pacific– PEST Analysis

4.2.4        Middle East & Africa

4.2.5        South & Central America

4.3       Expert Opinion

5.             Viral Antigens Market – Key Market Dynamics

5.1       Market Drivers

5.1.1        Increased Acceptance of Viral Antigens in Vaccine Development

5.1.2        Advancements in Image Analysis Software and Informatics Platforms for Viral Antigen Detection

5.2       Market Restraints

5.2.1        High Cost of Vaccine Development

5.3       Market Opportunities

5.3.1        Emerging Markets

5.4       Future Trends

5.4.1        Growing Trend of Plant-Made Vaccine Antigens and Biopharmaceuticals

5.5       Impact Analysis

6.             Viral Antigens Market – Global Analysis

6.1       Global Viral Antigens Market Revenue Forecast And Analysis

6.2       Global Viral Antigens Market, By Geography - Forecast And Analysis

6.3       Market Positioning of Key Players

7.             Viral Antigens Market– By Component

7.1       Overview

7.2       Viral Antigens Market Share, by Component, 2019 and 2027 (%)

7.3       Influenza Viral Antigens

7.3.1        Overview

7.3.2        Influenza Viral Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)

7.4       Coronavirus Antigens

7.4.1        Overview

7.4.2        Coronavirus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)

7.5       Zika Virus Antigens

7.5.1        Overview

7.5.2        Zika Virus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)

7.6       Ebola Virus Antigens

7.6.1        Overview

7.6.2        Ebola Virus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)

7.7       Dengue Virus Antigens

7.7.1        Overview

7.7.2        Dengue Virus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)

7.8       Herpes Simplex Virus (HSV) Viral Antigens

7.8.1        Overview

7.8.2        Herpes Simplex Virus (HSV) Viral Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)

7.9       Rotavirus Viral Antigens

7.9.1        Overview

7.9.2        Rotavirus Viral Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)

7.10    Hepatitis A-E Virus Antigens

7.10.1     Overview

7.10.2     Hepatitis A-E Virus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)

7.11    Measles Virus Antigens

7.11.1     Overview

7.11.2     Measles Virus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)

7.12    Mumps/Parotitis Virus Antigens

7.12.1     Overview

7.12.2     Mumps/Parotitis Virus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)

7.13    Others

7.13.1     Overview

7.13.2     Others: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)

8.             Viral Antigens Market Analysis – By Technique

8.1       Overview

8.2       Viral Antigens Market Revenue Share, by Technique (2019 and 2027)

8.3       ELISA

8.3.1        Overview

8.3.2        ELISA: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)

8.4       Immunoassay

8.4.1        Overview

8.4.2        Immunoassay: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)

8.5       Hemagglutination

8.5.1        Overview

8.5.2        Hemagglutination: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)

8.6       Radioimmunoassay (RIA)

8.6.1        Overview

8.6.2        Radioimmunoassay: Viral Antigens Market – Revenue and Forecast to 2027  (US$ Million)

8.7       Immunoperoxidase Staining

8.7.1        Overview

8.7.2        Immunoperoxidase Staining: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)

8.8       Immunofluorescence

8.8.1        Overview

8.8.2        Immunofluorescence: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)

8.9       Others

8.9.1        Overview

8.9.2        Others: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)

9.             Viral Antigens Market Analysis – By End User

9.1       Overview

9.2       Viral Antigens Market Share, by End User, 2019 and 2027, (%)

9.3       Hospitals

9.3.1        Overview

9.3.2        Hospitals: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)

9.4       Clinics

9.4.1        Overview

9.4.2        Clinics: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)

9.5       Laboratories

9.5.1        Overview

9.5.2        Laboratories: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)

9.6       Diagnostic Centres

9.6.1        Overview

9.6.2        Diagnostic Centres: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)

9.7       Blood Banks

9.7.1        Overview

9.7.2        Blood Banks: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)

9.8       Research Institutes

9.8.1        Overview

9.8.2        Research Institutes: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)

10.          Viral Antigens Market – Geographic Analysis

10.1    North America: Viral Antigens Market

10.1.1     Overview

10.1.2     North America: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.1.3     North America: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.1.4     North America: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.1.5     North America: Viral Antigens Market, by End User, 2018–2027 (USD Million)

10.1.6     North America: Viral Antigens Market, by Country, 2019 & 2027 (%)

10.1.7     US: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1    US: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2    US: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.1.7.3    US: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.1.7.4    US: Viral Antigens Market, by End User, 2018–2027 (USD Million)

10.1.8     Canada: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1    Canada: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2    Canada: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.1.8.3    Canada: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.1.8.4    Canada: viral antigens market, by End User, 2018–2027 (USD million)

10.1.9     Mexico: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1    Mexico: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2    Mexico: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.1.9.3    Mexico: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.1.9.4    Mexico: Viral Antigens Market, by End User, 2018–2027 (USD million)

10.2    Europe: Viral Antigens Market

10.2.1     Overview

10.2.2     Europe: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)

10.2.3     Europe: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.2.4     Europe: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.2.5     Europe: Viral Antigens Market, by End User, 2018–2027 (USD Million)

10.2.6     Germany: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.2.6.1    Germany: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.2.6.2    Germany: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.2.6.3    Germany: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.2.6.4    Germany: Viral Antigens Market, by End User, 2018–2027 (USD million)

10.2.7     UK: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.2.7.1    UK Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.2.7.2    UK: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.2.7.3    UK: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.2.7.4    UK: Viral Antigens Market, by End User, 2018–2027 (USD million)

10.2.8     France: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.2.8.1    France: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.2.8.2    France: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.2.8.3    France: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.2.8.4    France: Viral Antigens Market, by End User, 2018–2027 (USD million)

10.2.8.5    Spain: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.2.8.6    Spain: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.2.8.7    Spain: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.2.8.8    Spain: Viral Antigens Market, by End User, 2018–2027 (USD million)

10.2.9     Italy: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.2.9.1    Italy: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.2.9.2    Italy: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.2.9.3    Italy: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.2.9.4    Italy: Viral Antigens Market, by End User, 2018–2027 (USD million)

10.2.10   Rest of Europe: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.2.10.1 Rest of Europe: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.2.10.2 Rest of Europe: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.2.10.3 Rest of Europe: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.2.10.4 Rest of Europe: Viral Antigens Market, by End User, 2018–2027 (USD million)

10.3    Asia Pacific: Viral Antigens Market

10.3.1     Overview

10.3.2     Asia Pacific: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)

10.3.3     Asia Pacific: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.3.4     Asia Pacific: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.3.5     Asia Pacific: Viral Antigens Market, by End User, 2018–2027 (USD Million)

10.3.6     Asia Pacific: Viral Antigens Market, by Country, 2019 & 2027 (%)

10.3.7     China: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.3.7.1    China: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.3.7.2    China: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.3.7.3    China: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.3.7.4    China: Viral Antigens Market, by End User, 2018–2027 (USD million)

10.3.8     Japan: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.3.8.1    Japan: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.3.8.2    Japan: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.3.8.3    Japan: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.3.8.4    Japan: Viral Antigens Market, by End User, 2018–2027 (USD million)

10.3.9     India: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.3.9.1    India: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.3.9.2    India: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.3.9.3    India: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.3.9.4    India: Viral Antigens Market, by End User, 2018–2027 (USD million)

10.3.10   South Korea: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.3.10.1 South Korea: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.3.10.2 South Korea: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.3.10.3 South Korea: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.3.10.4 South Korea: Viral Antigens Market, by End User, 2018–2027 (USD million)

10.3.10.5 Australia: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.3.10.6 Australia: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.3.10.7 Australia: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.3.10.8 Australia: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.3.10.9 Australia: Viral Antigens Market, by End User, 2018–2027 (USD million)

10.3.11   Rest of Asia Pacific: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.3.11.1 Rest of Asia Pacific: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.3.11.2 Rest of Asia Pacific: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.3.11.3 Rest of Asia Pacific: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.3.11.4 Rest of Asia Pacific: Viral Antigens Market, by End User, 2018–2027 (USD million)

10.4    Middle East & Africa: Viral Antigens Market

10.4.1     Overview

10.4.2     Middle East & Africa: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)

10.4.3     Middle East & Africa: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.4.4     Middle East & Africa: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.4.5     Middle East & Africa: Viral Antigens Market, by End User, 2018–2027 (USD Million)

10.4.6     Middle East & Africa: Viral Antigens Market, by Country, 2019 & 2027 (%)

10.4.7     Saudi Arabia: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.4.7.1    Saudi Arabia: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.4.7.2    Saudi Arabia: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.4.7.3    Saudi Arabia: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.4.7.4    Saudi Arabia: Viral Antigens Market, by End User, 2018–2027 (USD million)

10.4.8     UAE: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.4.8.1    UAE: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.4.8.2    UAE: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.4.8.3    UAE: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.4.8.4    UAE: Viral Antigens Market, by End User, 2018–2027 (USD million)

10.4.9     South Africa: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.4.9.1    South Africa: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.4.9.2    South Africa: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.4.9.3    South Africa: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.4.9.4    South Africa: Viral Antigens Market, by End User, 2018–2027 (USD million)

10.4.10   Rest of Middle East and Africa: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.4.10.1 Rest of Middle East and Africa: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.4.10.2 Rest of Middle East and Africa: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.4.10.3 Rest of Middle East and Africa: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.4.10.4 Rest of Middle East and Africa: Viral Antigens Market, by End User, 2018–2027 (USD million)

10.5    South and Central America: Viral Antigens Market

10.5.1     Overview

10.5.2     South and Central America: Viral Antigens Market, by Country, 2019 & 2027 (%)

10.5.3     South and Central America: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.5.4     South and Central America: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.5.5     South and Central America: Viral Antigens Market, by End User, 2018–2027 (USD Million)

10.5.6     South and Central America: Viral Antigens Market, by Country, 2019 & 2027 (%)

10.5.7     Brazil: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.5.7.1    Brazil: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.5.8     Brazil: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.5.9     Brazil: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.5.10   Brazil: Viral Antigens Market, by End User, 2018–2027 (USD Million)

10.5.11   Argentina: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.5.11.1 Argentina: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.5.12   Argentina: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.5.13   Argentina: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.5.14   Argentina: Viral Antigens Market, by End User, 2018–2027 (USD Million)

10.5.15   Rest of Central and South America: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.5.15.1 Rest of Central and South America: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

10.5.16   Rest of Central and South America: Viral Antigens Market, by Component, 2018–2027 (USD Million)

10.5.17   Rest of Central and South America: Viral Antigens Market, by Technique, 2018–2027 (USD Million)

10.5.18   Rest of Central and South America: Viral Antigens Market, by End User, 2018–2027 (USD Million)

11.          Impact of COVID-19 Pandemic on Global Viral Antigens Market

11.1    North America: Impact Assessment of COVID-19 Pandemic

11.2    Europe (EU): Impact Assessment of COVID-19 Pandemic

11.3    Asia-Pacific: Impact Assessment of COVID-19 Pandemic

11.4    Middle East & Africa: Impact Assessment of COVID-19 Pandemic

11.5    South and Central America: Impact Assessment of COVID-19 Pandemic

12.          Viral Antigens Market– Industry Landscape

12.1    Overview

12.2    Growth Strategies Done by the Companies in the Market, (%)

12.3    Organic Developments

12.3.1     Overview

12.4    Inorganic Developments

12.4.1     Overview

13.          Company Profiles

13.1    Microbix Biosystems

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2    BIO-RAD LABORATORIES INC.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3    Creative Diagnostics

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4    Aalto Bio Reagents Ltd.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5    Advanced Biotechnologies Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6    Prospec-Tany Technogene Ltd.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7    ACROBiosystems.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8    MERIDIAN BIOSCIENCE, INC.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9    Rekom Biotech S.L

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10 LGC Limited.

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Products and Services

13.10.4   Financial Overview

13.10.5   SWOT Analysis

13.10.6   Key Developments

14.          Appendix

14.1    About The Insight Partners

14.2    Glossary of Terms 


LIST OF TABLES

Table 1.             Viral Antigens Market Share, by Component, 2019 and 2027 (%)

Table 2.             North America Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 3.             North America Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 4.             North America Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 5.             US Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 6.             US Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 7.             US Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 8.             Canada Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 9.             Canada Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 10.          Canada Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 11.          Mexico Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 12.          Mexico Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 13.          Mexico Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 14.          Europe Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 15.          Europe Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 16.          Europe Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 17.          Europe: Viral Antigens Market, by Country, 2019 & 2027 (%)

Table 18.          Germany Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 19.          Germany Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 20.          Germany Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 21.          UK Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 22.          UK Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 23.          UK Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 24.          France Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 25.          France Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 26.          France Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 27.          Spain: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

Table 28.          Spain Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 29.          Spain Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 30.          Spain Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 31.          Italy Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 32.          Italy Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 33.          Italy Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 34.          Rest of Europe Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 35.          Rest of Europe Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 36.          Rest of Europe Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 37.          Asia Pacific Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 38.          Asia Pacific Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 39.          Asia Pacific Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 40.          China Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 41.          China Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 42.          China Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 43.          Japan Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 44.          Japan Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 45.          Japan Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 46.          India Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 47.          India Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 48.          India Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 49.          South Korea Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 50.          South Korea Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 51.          South Korea Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 52.          Australia Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 53.          Australia Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 54.          Australia Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 55.          Rest of Asia Pacific Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 56.          Rest of Asia Pacific Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 57.          Rest of Asia Pacific Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 58.          Middle East & Africa Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 59.          Middle East & Africa Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 60.          Middle East & Africa Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 61.          Saudi Arabia Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 62.          Saudi Arabia Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 63.          Saudi Arabia Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 64.          UAE Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 65.          UAE Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 66.          UAE Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 67.          South Africa Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 68.          South Africa Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 69.          South Africa Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 70.          Rest of Middle East and Africa Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 71.          Rest of Middle East and Africa Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 72.          Rest of Middle East and Africa Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 73.          South and Central America Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 74.          South and Central America Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 75.          South and Central America Viral Antigens Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 76.          Brazil Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 77.          Brazil Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 78.          Brazil Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 79.          Argentina Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 80.          Argentina Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 81.          Argentina Viral Antigens Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 82.          Rest of Central and South America Viral Antigens Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 83.          Rest of Central and South America Viral Antigens Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 84.          Rest of Central and South America Viral Antigens Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 85.          Organic Developments Done By Companies

Table 86.          Inorganic Developments Done By Companies

Table 87.          Glossary of Terms, Viral antigens Market

 

LIST OF FIGURES

Figure 1.           Viral Antigens Market Segmentation

Figure 2.           Viral Antigens Market, By Region

Figure 3.           Global Viral Antigens Market Overview

Figure 4.           The Coronavirus Antigens Segment Held Largest Share of Component Segment In Viral Antigens Market

Figure 5.           Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Global Viral Antigens Market, By Geography (USD Million)

Figure 7.           Global Viral Antigens Market- Leading Country Markets (USD Million)

Figure 8.           Global Viral Antigens Market, Industry Landscape

Figure 9.           North America PEST Analysis

Figure 10.        Europe PEST Analysis

Figure 11.        Asia Pacific PEST Analysis

Figure 12.        Middle East & Africa Analysis

Figure 13.        South & Central America PEST Analysis

Figure 14.        Expert Opinion

Figure 15.        Global Viral Antigens Market – Revenue Forecast And Analysis – 2019- 2027

Figure 16.        Global Viral Antigens Market – By Geography Forecast and Analysis – 2019- 2027

Figure 17.        Market Positioning Of Key Players In Global Viral Antigens Market

Figure 18.        Viral Antigens Market Share, by Component, 2019 and 2027 (%)

Figure 19.        Influenza Viral Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)

Figure 20.        Coronavirus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)

Figure 21.        Zika Virus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)

Figure 22.        Ebola Virus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)

Figure 23.        Dengue Virus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)

Figure 24.        Herpes Simplex Virus (HSV) Viral Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)

Figure 25.        Rotavirus Viral Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)

Figure 26.        Hepatitis A-E Virus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)

Figure 27.        Measles Virus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)

Figure 28.        Mumps/Parotitis Virus Antigens: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)

Figure 29.        Others: Viral Antigens Market– Revenue and Forecast to 2027 (USD Million)

Figure 30.        Viral Antigens Market Revenue Share, by Technique (2019 and 2027)

Figure 31.        ELISA: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)

Figure 32.        Immunoassay: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)

Figure 33.        Hemagglutination: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)

Figure 34.        Radioimmunoassay: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)

Figure 35.        Immunoperoxidase Staining: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)

Figure 36.        Immunofluorescence: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)

Figure 37.        Others: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)

Figure 38.        Viral Antigens Market Share, by End User, 2019 and 2027 (%)

Figure 39.        Hospitals: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)

Figure 40.        Clinics: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)

Figure 41.        Laboratories: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)

Figure 42.        Diagnostic Centres: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)

Figure 43.        Blood Banks: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)

Figure 44.        Research Institutes: Viral Antigens Market – Revenue and Forecast to 2027 (US$ Million)

Figure 45.        North America: Viral Antigens Market, by Key Country – Revenue (2019) (USD Million)

Figure 46.        North America Viral Antigens Market Revenue and Forecast to 2027 (USD Million)

Figure 47.        North America: Viral Antigens Market, by Country, 2019 & 2027 (%)

Figure 48.        US: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

Figure 49.        Canada: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

Figure 50.        Mexico: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

Figure 51.        Europe: Viral Antigens Market, by Key Country – Revenue (2019) (USD Million)

Figure 52.        Europe Viral Antigens Market Revenue and Forecast to 2027 (USD Million)

Figure 53.        Europe: Viral Antigens Market, by Country, 2019 & 2027 (%)

Figure 54.        Germany: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

Figure 55.        UK: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

Figure 56.        France: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

Figure 57.        Spain: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

Figure 58.        Italy: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

Figure 59.        Rest of Europe: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

Figure 60.        Asia Pacific: Viral Antigens Market, by Key Country – Revenue (2019) (USD Million)

Figure 61.        Asia Pacific Viral Antigens Market Revenue and Forecast to 2027 (USD Million)

Figure 62.        China: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

Figure 63.        Japan: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

Figure 64.        India: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

Figure 65.        South Korea: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

Figure 66.        Australia: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

Figure 67.        Rest of Asia Pacific: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

Figure 68.        Middle East & Africa: Viral Antigens Market, by Key Country – Revenue (2019) (USD Million)

Figure 69.        Middle East & Africa Viral Antigens Market Revenue and Forecast to 2027 (USD Million)

Figure 70.        Middle East & Africa: Viral Antigens Market, by Country, 2019 & 2027 (%)

Figure 71.        Saudi Arabia: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

Figure 72.        UAE: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

Figure 73.        South Africa: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

Figure 74.        Rest of Middle East and Africa: Pulse Oximeters Market – Revenue and Forecast to 2027 (USD Million)

Figure 75.        South and Central America: Viral Antigens Market, by Key Country – Revenue (2019) (USD Million)

Figure 76.        South and Central America: Viral Antigens Market, by Country, 2019 & 2027 (%)

Figure 77.        South and Central America: Viral Antigens Market, by Country, 2019 & 2027 (%)

Figure 78.        Brazil: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

Figure 79.        Argentina: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

Figure 80.        Rest of Central and South America: Viral Antigens Market – Revenue and Forecast to 2027 (USD Million)

Figure 81.        Impact of COVID-19 Pandemic in North American Country Markets

Figure 82.        Impact of COVID-19 Pandemic in Europe Country Markets

Figure 83.        Impact of COVID-19 Pandemic in Asia-Pacific Country Markets

Figure 84.        Impact of COVID-19 Pandemic in Middle East & Africa Market

Figure 85.        Impact of COVID-19 Pandemic in South and Central America Market

Figure 86.        Growth Strategies Done by the Companies in the Market, (%)

 

 

 

The List of Companies - Viral Antigens Market

  1. Microbix Biosystems
  2. BIO-RAD LABORATORIES INC.
  3. Creative Diagnostics
  4. Aalto Bio Reagents Ltd.
  5. Advanced Biotechnologies Inc.
  6. Prospec-Tany Technogene Ltd.
  7. ACROBiosystems.
  8. MERIDIAN BIOSCIENCE, INC.
  9. Rekom Biotech S.L
  10.  LGC Limited

 

 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the viral antigens market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global viral antigens market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
TIPRE00017334
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

A virus can infect all types of life forms, from plants and animals to archaea and bacteria. A virus antigen is a poison or toxic substance administered by a virus that induces an immune reaction in its host. A viral protein is an antigen identified by the viral genome that can be recognized through a particular immunological response. A viral antigen is determined by IFA in neutrophils and platelets from bone marrow or blood or in serum, saliva, tears, or plasma by ELISA. Nucleic amplification tests can also be used to determine the stage of infection. The best outcomes are obtained when antigens are measured through blood tests or serum.

The global viral antigens market is being driven by factors such increased acceptance of viral antigens in vaccine development and advancements in image analysis software and informatics platforms for viral antigen detection. Furthermore, emerging markets is likely to offer significant opportunities for the growth of the global viral antigens market.

The high cost of vaccine development is the significant factor that will hinder the viral antigens market growth.

Pricing